Shifamad Pharmaceutical Private Limited
About Shifamad Pharmaceutical Private Limited
Data last updated:
Shifamad Pharmaceutical Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 18 December 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2012PTC246389. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Neelaufar and Akram Baig.
Its last annual general meeting (AGM) was held on 30 September 2022, and its latest financial statements are for the year ended 31 March 2022. The registered office is at 313/49B Inderlok, Delhi, India – 110035.
As per the financials filed for FY 2020, the company reported a revenue of ₹65,650. For the same year it recorded a net loss of ₹21,850 (net margin -33.3%) and EBITDA of -₹1,850 (EBITDA margin -2.8%). Revenue has grown at a compounded annual rate (CAGR) of 43% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Shifamad Pharmaceutical Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address313/49B Inderlok, Delhi, India – 110035
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Shifamad Pharmaceutical Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Shifamad Pharmaceutical Private Limited
FY 2022 filings availableShifamad Pharmaceutical Private Limited reported revenue of ₹65,650 for FY 2020.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 43% over three years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | ₹65,650 | ||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1,850 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹21,850 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2019-20 | FY 2018-19 | FY 2017-18 | FY 2016-17 | FY 2015-16 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -2.8% | ||||
| Net Profit Margin | -33.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Shifamad Pharmaceutical Private Limited, buy the company report.
Board of directors of Shifamad Pharmaceutical Private Limited
Shifamad Pharmaceutical has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Neelaufar | Director | 18 Jan 2014 | 12 Years 9 Months | Current |
| Akram Baig | Director | 18 Dec 2012 | 13 Years 10 Months | Current |
Auditor
Shifamad Pharmaceutical Private Limited is audited by SDM&CO for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SDM&CO | FY 2017 | 020110N |
Shareholding
The shareholding of Shifamad Pharmaceutical Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Shifamad Pharmaceutical Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Shifamad Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Shifamad Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Shifamad Pharmaceutical has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Shifamad Pharmaceutical Private Limited, buy the company report.
Recent activity
Shifamad Pharmaceutical Private Limited has 3 board changes on record since 2012: 2 appointments and 1 cessation. The latest: Imran Ghauri ceased to be Director on 18 Jan 2014.
Frequently asked questions
Shifamad Pharmaceutical is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 18 December 2012 (14+ years old) and is registered under CIN U24232DL2012PTC246389.
Shifamad Pharmaceutical has 2 current directors:
- Neelaufar - Director
- Akram Baig - Director
The latest financial statements of Shifamad Pharmaceutical on record with the MCA are for the year ended 31 March 2022. Its last annual general meeting was held on 30 September 2022. Year-wise statements from 2015 are in the company report.
No. Shifamad Pharmaceutical has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Shifamad Pharmaceutical is U24232DL2012PTC246389. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Shifamad Pharmaceutical was incorporated on 18 December 2012, making it 14+ years old. It is registered with the Registrar of Companies, Delhi.
Imran Ghauri ceased to be Director on 18 Jan 2014. Neelaufar was appointed as Director on 18 Jan 2014. Akram Baig was appointed as Director on 18 Dec 2012.
The registered office of Shifamad Pharmaceutical is at 31349B Inderlok, Delhi, India – 110035.
Shifamad Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
The compliance status of Shifamad Pharmaceutical is compliant as of 05 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
